Farmaindustria y Biocat conectan siete proyectos de investigación catalanes con compañías farmacéuticas para impulsar el desarrollo de nuevos fármacos

by Farmaindustria

La XXV edición del Programa Farma-Biotech, que busca fomentar la investigación preclínica y traslacional, se ha centrado en esta ocasión en proyectos de Cataluña

Read more

ICH Q3 Impurity Guidelines: Analytical Strategies for Safer Drug Development

by AMSbiopharma

Impurities in pharmaceuticals can compromise the safety, efficacy, and stability of a product. To safeguard public health, global regulatory authorities such as the International Council for Harmonisa...

Read more

Parc Taulí begins a clinical study to test a new oncology drug in humans for the first time

by Instituto de Investigación e Innovación Parc Taulí

The study will evaluate the safety and efficacy of the molecule IMP1734, a selective inhibitor that blocks a key enzyme for DNA repair in cancer cells.

Read more

ORYZON continues to strengthen its patent portfolio for the vafidemstat

by Oryzon Genomics

It has been today announced that they has received “Decision to grant” communications from the Canadian Intellectual Property Office and the Israel Patent Office for its patent applications CA3071...

Read more

Inveready successfully closes Inveready Innvierte Biotech II with a 4.3x return on capital invested by shareholders

by CATALONIA.HEALTH

The financial services company Inveready, a member of Catalonia.health, announces the successful closure of its life sciences fund Inveready Innvierte Biotech II. This is the second fund the firm has ...

Read more

New clinical trial targets the most common form of skin cancer with a compound based on CNIO discoveries

by CNIO - Centro Nacional de Investigaciones Oncológicas

Highlight Therapeutics and CNIO are collaborating to proof BO-112 effectiveness against the most common form of skin cancer, which is linked to sun exposure and is on the rise.

Read more

Researchers at IBS.GRANADA are developing compounds with therapeutic potential against triple-negative breast cancer.

by Instituto de Investigación Biosanitaria - Ibs Granada

The study, published in the journal Bioorganic Chemistry, identifies molecules capable of blocking a key interaction in the progression of this type of tumor.

Read more

ICH Guidelines for Analytical Method Validation: Principles, Requirements and Industry Applications

by AMSbiopharma

In pharmaceutical development, validating analytical methods goes further than regulatory formality. It is a critical component of ensuring reliable, reproducible, and scientifically sound data. The I...

Read more

ORYZON receives European Medicines Agency approval to initiate a Phase Ib study of iadademstat in sickle cell disease

by Oryzon Genomics

Oryzon Genomics, a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (...

Read more

Preclinical Research in Drug Development: From Toxicology to Translational Insights

by AMSbiopharma

Through a series of well-established scientific assessments, ranging from toxicology assessments to pharmacokinetics and efficacy models, preclinical research generates essential data to support Inves...

Read more

Pharma Quality Control Strategies for Drug Development and Regulatory Compliance

by AMSbiopharma

As drug candidates move from early research through commercial production, robust pharma quality control strategies become the backbone of safe, effective, and regulatory-compliant medicines. The inte...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream